Alberto Romero-Maté

Alberto Romero-Maté

Auto-generated profile, based on publicly available information

Alberto Romero-Maté

Department of Dermatology, Fuenlabrada University Hospital, Madrid, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
LBLaura Botana
Laura Botana
BMBelén Matía
Belén Matía
JMJuan San Martín
Juan San Martín
ARAlberto Romero-Maté
Alberto Romero-Maté
ACAlicia Castro
Alicia Castro
JMJavier Moreno
Javier Moreno
Increased numbers of peripheral blood mononucleocytes (PBMC) and increased IFN-γ secretion following in vitro challenge of blood samples with soluble Leishmania antigen (SLA), have been proposed as biomarkers of specific cell-mediated immunity, indicating that treatment of visceral leishmaniasis (VL) has been successful. However, Leishmania infantum infection may manifest as cutaneous leishmaniasis (CL), and less commonly as localized leishmanial lymphadenopathy (LLL) or mucosal leishmaniasis (ML). The present work examines the value of these biomarkers as indicators of cured leishmaniasis presenting in these different forms. Blood samples were collected before and after treatment from patients living in Fuenlabrada (Madrid, Spain), an L. infantum-endemic area recently the center of a leishmaniasis outbreak. All samples were subjected to Leishmania-specific PCR, serological tests (IFAT and rK39-ICT), and the SLA-cell proliferation assay (SLA-CPA), recording PBMC proliferation and the associated changes in IFN-γ production. Differences in the results recorded for the active and cured conditions were only significant for VL. PCR returned positive results in 67% of patients with active VL and in 3% of those with cured leishmaniasis. Similarly, rK39-ICT returned a positive result in 77% of active VL samples vs. 52% in cured VL samples, and IFAT in 90% vs. 56%; in the SLA-CPA, PBMC proliferation was seen in 16% vs. 90%, and an associated increase in IFN-γ production of 14 and 84%, respectively. The present findings reinforce the idea that PBMC proliferation and increased IFN-γ production in SLA-stimulated PBMC provide biomarkers of clinical cure in VL. Other tests are urgently needed to distinguish between the cured and active forms of the other types of clinical leishmaniasis caused by L. infantum.

1 January 2017 in Dermatology Online Journal
Verified
Journal Article
Open access
PDF file
ARAlberto Romero-Maté
Alberto Romero-Maté
CGCarmen García-Donoso
Carmen García-Donoso
AHAlmudena Hernández-Núñez
Almudena Hernández-Núñez
CMCristina Martínez-Morán
Cristina Martínez-Morán
AMAmalia Moreno-Torres
Amalia Moreno-Torres
JBJesús Borbujo-Martínez
Jesús Borbujo-Martínez
We report a 52-year old woman with a 28-year historyof disfiguring facial discoid lupus erythematosus(DLE), persistent despite both classical therapiesand rituximab. Ustekinumab 45 mg was started incombination with methotrexate and intralesionalcorticosteroids. Methotrexate and intralesionalcorticosteroids were withdrawn 30 months later andustekinumab maintained as monotherapy. Fortyeight months later stable improvement was achievedwithout side effects. Only nine patients with cutaneouslupus erythematosus (CLE) treated with ustekinumabhave been reported to date. Ustekinumab could be apromising alternative in severe and recalcitrant casesof CLE. Possibly, the Th17-inflammation pathway isplaying a role in these patients.

24 July 2015 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MUM. Utrera-Busquets
M. Utrera-Busquets
ARA. Romero-Maté
A. Romero-Maté
ÁCÁ. Castaño
Á. Castaño
LAL. Alegre
L. Alegre
CGC. García-Donoso
C. García-Donoso
JBJ. Borbujo
J. Borbujo

1 October 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ARAlberto Romero-Maté
Alberto Romero-Maté
DADolores Arias-Palomo
Dolores Arias-Palomo
AHAlmudena Hernández-Núñez
Almudena Hernández-Núñez
SCSusana Córdoba-Guijarro
Susana Córdoba-Guijarro
JBJesús Borbujo-Martínez
Jesús Borbujo-Martínez

1 January 2019 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
JCJaime Company-Quiroga
Jaime Company-Quiroga
SASergio Alique-García
Sergio Alique-García
CMCristina Martínez-Morán
Cristina Martínez-Morán
RKRadia Khedaoui
Radia Khedaoui
ARAlberto Romero-Maté
Alberto Romero-Maté
JBJesús Borbujo
Jesús Borbujo
Indian J Dermatol Venereol Leprol, Official publication of Indian Prosthodontic Society

31 January 2023 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
GBGloria Baeza-Hernández
Gloria Baeza-Hernández
MVMaría de la Soledad Vallejo-Ruiz
María de la Soledad Vallejo-Ruiz
RRRicardo Francisco Rubio-Aguilera
Ricardo Francisco Rubio-Aguilera
ARAlberto Romero-Maté
Alberto Romero-Maté
CMCristina Martínez-Morán
Cristina Martínez-Morán
Citation: Baeza-Hernández G, de la Soledad Vallejo-Ruiz M, Rubio-Aguilera RF, Romero-Maté A, Martínez-Morán C. An Unexpected Dermatophyte? Two Remarkable Cases of Tinea Barbae by Trichophyton benhamiae. Dermatol Pract Concept. 2023;13(1):e2023037. DOI: https://doi.org/10.5826/dpc.1301a37 Accepted: June 13, 2022; Published: January 2023 Copyright: ©2023 Baeza-Hernández et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Gloria Baeza-Hernández, Servicio de Dermatología, Hospital de Fuenlabrada, Camino del Molino 2, 28942 Fuenlabrada, Madrid, Spain. E-mail: gloria.baeza@salud.madrid.org Keywords : Trichophyton benhamiae, Arthroderma benhamiae, tinea barbae, dermatophytosis, terbinafine This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.